Meaghan Malley is the Senior Project Associate for the Kidney Health Initiative (KHI) at the ASN Alliance for Kidney Health (ASN). KHI is a public-private partnership between ASN, the U.S. Food and Drug Administration and over 100 member companies and organizations focused on fostering innovation and enhancing patient safety in kidney disease. Since joining the program in 2018, Ms. Malley has led several efforts focused on endpoints for clinical trials in rare kidney diseases where treatment options were limited for patients. Additionally, in partnership with the KHI Board of Directors, she leads the program’s strategic efforts to catalyze innovation and facilitate the development of safe and effective patient-centered therapies for people.